APP and early-onset autosomal dominant Alzheimer disease: Considering some common features between the Aβ peptides involved in Alzheimer’s Disease and κ-casein amyloid structures, including the cross-beta spine of the inner core [70] and the potential role of micellar conformations [52,53], we also verified that APP inhibit the aggregation of the Aβ1–42 peptide involved in Alzheimer’s Disease.